EPSTEIN-BARR VIRUS INFECTION
Clinical trials for EPSTEIN-BARR VIRUS INFECTION explained in plain language.
Never miss a new study
Get alerted when new EPSTEIN-BARR VIRUS INFECTION trials appear
Sign up with your email to follow new studies for EPSTEIN-BARR VIRUS INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Moderna tests First-Ever mRNA shot against 'Mononucleosis' virus
⭐️ VACCINE ⭐️ OngoingThis is the first human study of Moderna's experimental mRNA vaccine designed to protect against Epstein-Barr virus (EBV), which causes mononucleosis and is linked to several cancers. The trial will test the vaccine's safety and how well it triggers an immune response in 482 heal…
Matched conditions: EPSTEIN-BARR VIRUS INFECTION
Phase: PHASE1 • Sponsor: ModernaTX, Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 30, 2026 14:34 UTC
-
First-Ever EBV vaccine trial seeks to stop 'Mono' virus that causes fatigue and cancer risk
⭐️ VACCINE ⭐️ OngoingThis early-stage clinical trial is testing a new vaccine designed to prevent infection with Epstein-Barr virus (EBV), which causes mononucleosis ('mono') and is linked to certain cancers. The study involves healthy young adults aged 18-25 who have never had EBV before. Participan…
Matched conditions: EPSTEIN-BARR VIRUS INFECTION
Phase: PHASE1, PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 25, 2026 14:07 UTC
-
Blood test guides chemo choice in cancer trial
Disease control OngoingThis study is testing a personalized approach to treat nasopharyngeal cancer, a type of head and neck cancer linked to the Epstein-Barr virus. All participants first receive standard radiation and chemotherapy. Afterward, their treatment is customized based on whether a specific …
Matched conditions: EPSTEIN-BARR VIRUS INFECTION
Phase: PHASE2, PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC